TY - JOUR
T1 - Corrigendum to “Clinical and genetic studies in patients with Lafora disease from Pakistan” [J. Neurol. Sci. 373 (2017) 263–267] (S0022510X17300084)(10.1016/j.jns.2017.01.010)
AU - Ahmad, Arsalan
AU - Dad, Rubina
AU - Ullah, Muhammad Ikram
AU - Baig, Tahir Ahmed
AU - Ahmad, Imran N.
AU - Nasir, Abdul
AU - Hübner, Christian A.
AU - Hassan, Muhammad Jawad
N1 - Publisher Copyright:
© 2017
PY - 2017/4/15
Y1 - 2017/4/15
N2 - The authors regret that there were mistakes in the published version of this paper. These mistakes and their correction are detailed below: Published: Ahmad et al., 2017 clinical short communication, JNS15072, entitled, “Clinical and genetic studies in patients with Lafora disease from Pakistan” Volume 373, 15 February 2017, Pages 263–267. 4. Discussion Lafora disease is one of the rare neuro-developmental diseases of early adolescent. It is presented with diverse clinical features like abnormal social interactions, continuous seizures, ataxia and intellectual disability, decline of neuronal functions and loss of motor movements at later stages of the disease [21]. Worldwide, the approximate prevalence of epilepsy is 8% in general population while in developing countries a higher burden of this disease is found with rate of prevalence between 10 and 40% [22, 23]. Similarly, in Pakistan prevalence is presumed to be high but no data is available. Corrected: Lafora disease is one of the rare neuro-developmental diseases of early adolescent. It is presented with diverse clinical features like abnormal social interactions, continuous seizures, ataxia and intellectual disability, decline of neuronal functions and loss of motor movements at later stages of the disease [21]. Worldwide, the approximate prevalence of epilepsy is 8–10/1000 in general population while in developing countries a higher burden of this disease is found [22, 23]. A study from southern Pakistan indicates an age-specific prevalence rate of 9.99/1000 (14.8/1000 in rural and 7.4/1000 in urban areas) for recurrent, non-febrile, active epilepsy [27]. [27] Aziz H, Ali SM, Frances P, Khan MI, Hasan KZ. Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia, 1994; 35(5):950–958. Key: 1- “8%” was changed to 8/1000.2- “with rate of prevalence between 10 and 40%” was deleted.3- “Similarly, in Pakistan prevalence is presumed to be high but no data is available” was changed to “A study from southern Pakistan indicates an age-specific prevalence rate of 9.99/1000 (14.8/1000 in rural and 7.4/1000 in urban areas) for recurrent, non-febrile, active epilepsy [27]”.4- Reference was added “Aziz H, Ali SM, Frances P, Khan MI, Hasan KZ. Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia, 1994; 35(5):950–958”.
AB - The authors regret that there were mistakes in the published version of this paper. These mistakes and their correction are detailed below: Published: Ahmad et al., 2017 clinical short communication, JNS15072, entitled, “Clinical and genetic studies in patients with Lafora disease from Pakistan” Volume 373, 15 February 2017, Pages 263–267. 4. Discussion Lafora disease is one of the rare neuro-developmental diseases of early adolescent. It is presented with diverse clinical features like abnormal social interactions, continuous seizures, ataxia and intellectual disability, decline of neuronal functions and loss of motor movements at later stages of the disease [21]. Worldwide, the approximate prevalence of epilepsy is 8% in general population while in developing countries a higher burden of this disease is found with rate of prevalence between 10 and 40% [22, 23]. Similarly, in Pakistan prevalence is presumed to be high but no data is available. Corrected: Lafora disease is one of the rare neuro-developmental diseases of early adolescent. It is presented with diverse clinical features like abnormal social interactions, continuous seizures, ataxia and intellectual disability, decline of neuronal functions and loss of motor movements at later stages of the disease [21]. Worldwide, the approximate prevalence of epilepsy is 8–10/1000 in general population while in developing countries a higher burden of this disease is found [22, 23]. A study from southern Pakistan indicates an age-specific prevalence rate of 9.99/1000 (14.8/1000 in rural and 7.4/1000 in urban areas) for recurrent, non-febrile, active epilepsy [27]. [27] Aziz H, Ali SM, Frances P, Khan MI, Hasan KZ. Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia, 1994; 35(5):950–958. Key: 1- “8%” was changed to 8/1000.2- “with rate of prevalence between 10 and 40%” was deleted.3- “Similarly, in Pakistan prevalence is presumed to be high but no data is available” was changed to “A study from southern Pakistan indicates an age-specific prevalence rate of 9.99/1000 (14.8/1000 in rural and 7.4/1000 in urban areas) for recurrent, non-febrile, active epilepsy [27]”.4- Reference was added “Aziz H, Ali SM, Frances P, Khan MI, Hasan KZ. Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia, 1994; 35(5):950–958”.
UR - http://www.scopus.com/inward/record.url?scp=85012170405&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2017.02.010
DO - 10.1016/j.jns.2017.02.010
M3 - Comment/debate
C2 - 28320149
AN - SCOPUS:85012170405
SN - 0022-510X
VL - 375
SP - 281
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
ER -